Collaborations
Continuing identification of new opportunities…
Interleukin Genetics has viewed external collaborations as a fundamental part of its business, and the company is always looking to evaluate promising opportunities. Interleukin has partnered with universities, research institutions, and private companies to discover, develop and commercialize products that improve personal health.
Our strategy is to develop test products for our own business needs and perform R&D services for partners interested in developing a companion diagnostic for their products. Our goal is to commercialize R&D test products and services through strategic alliances. We are also interested in in-licensing products or intellectual property to create new products. Our genetic testing business will continue to explore high potential markets such as weight management, osteoporosis, and arthritis, where there is a clear unmet medical need for improved care. Our research and development initiatives will continue to enhance our intellectual property position, ensure commercial and technical success of our products and develop formulary solutions that enable our partners to offer prevention and intervention therapeutics in a consumer and/or medical segment.
  |